Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
GMP-FINH18 | Human | GMP Recombinant Human Fibronectin fragment | ![]() |
![]() ![]() ![]() ![]() |
|
FIN-H5116 | Human | Recombinant Fibronectin fragment, premium grade | ![]() |
![]() ![]() ![]() ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Ocriplasmin | A-01016; THR-409 | Approved | Thrombogenics | Jetrea, Jejetrea | United States | Vitreomacular Adhesion | Thrombogenics Inc | 2012-10-17 | Vitreous Detachment; Arterial Occlusive Diseases; Disease Progression; Stroke; Retinal Diseases; Diabetic macular oedema; Uveitis; Vitreomacular Adhesion; Eye Diseases; Venous Thrombosis; Macular Degeneration; Diabetic Retinopathy; Retinal Vein Occlusion | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Onfekafusp alfa | Phase 3 Clinical | Philogen Spa | Solid tumours; Glioblastoma; Sarcoma; Breast Neoplasms; Genital Neoplasms, Female; Colorectal Neoplasms; Glioma; Lung Neoplasms; Melanoma | Details | |
Darleukin/fibromun | L19-IL-2/ L19-TNF-α | Phase 3 Clinical | Philogen Spa | Carcinoma, Merkel Cell; Carcinoma, Basal Cell; Carcinoma, Skin Appendage; Keratoacanthoma; Basal Cell Nevus Syndrome; Carcinoma, Squamous Cell; Lymphoma, T-Cell, Cutaneous; Melanoma; Sarcoma, Kaposi | Details |
Bifikafusp alfa | L19-IL-2 | Phase 3 Clinical | Philogen Spa | Solid tumours; Adenomatous Polyposis Coli; Pancreatic Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung | Details |
Radretumab | L19-I131; L19-SIP; I-L19-SIP; I-131-L19-SIP; 131I-L19-SIP; L19-131-I; 131I-radretumab; 131I-L19SIP; L19-131I | Phase 2 Clinical | Philogen Spa | Hematologic Neoplasms; Hodgkin Disease; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
PYX-201 | PYX-201 | Phase 2 Clinical | Pfizer Inc | Solid tumours | Details |
F8-IL10 | F8-IL10; PF-06687234 | Phase 2 Clinical | Philogen Spa | Inflammatory Bowel Diseases; Arthritis, Rheumatoid; Colitis, Ulcerative | Details |
177Lu-B5-IgG4 | 177-Lu-B5-IgG4 | Phase 1 Clinical | Affiliated Hospital of Jiangnan University | Solid tumours | Details |
This web search service is supported by Google Inc.